Therefore, we finally sought to investigate whether our pharmacologically induced CXCR2 LOF mice also display increased susceptibility to Streptococcus pneumoniae infection and whether CXCR4 antagonism could mitigate this susceptibility. This evidence concerns the gene CXCR4 and pneumococcal infection.